Sort
261,768 grants matching “gene therapy”
Development of an interferon-alpha-veltuzumab conjugate for CD20-targeted therapy
$2,283,892Edmund A Rossi · Immunomedics, Inc. · R44 · FY2011 · CA
Molecular Center of Health and Disease
$2,283,750Michael R Garrett · University Of Mississippi Med Ctr · P20 · FY2023 · GM
Weill Cornell Medicine (WCM) SPORE in Prostate Cancer
$2,283,108Massimo F Loda · Weill Medical Coll Of Cornell Univ · P50 · FY2018 · CA
Disease mechanism and therapies for retinal degeneration
$2,283,094Tiansen Li · National Eye Institute · ZIA · FY2019 · EY
Molecular Center of Health and Disease
$2,282,949Michael R Garrett · University Of Mississippi Med Ctr · P20 · FY2024 · GM
Genetics and Genomics of Leiomyosarcoma (LMS): Improved understanding of cancer biology and new approaches to diagnosis and treatment
$2,282,833Scott Michael Schuetze · University Of Michigan At Ann Arbor · P50 · FY2022 · CA
p53, Aging, and Cancer
$2,282,517Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Investigating and targeting apolipoprotein E4 in Down syndrome-associated Alzheimer's disease
$2,282,487Noah Ray Johnson · University Of Colorado Denver · RF1 · FY2023 · AG
A Controlled Clinical Trial of Regadenoson in Sickle Cell Anemia
$2,282,414David G. Nathan · Dana-Farber Cancer Inst · P50 · FY2012 · HL
Novel Mechanisms of Cardiac Injury and Repair
$2,281,940Walter J Koch · Temple Univ Of The Commonwealth · P01 · FY2015 · HL
The Memorial Sloan Kettering Cancer Center SPORE in Pancreas Cancer
$2,281,895Eileen Mary O'Reilly · Sloan-Kettering Inst Can Research · P50 · FY2024 · CA
KnowEng, a Scalable Knowledge Engine for Large-Scale Genomic Data-OVERALL
$2,281,452Jiawei Han · University Of Illinois At Urbana-Champaign · U54 · FY2015 · GM
Architecture and control of exocytosis and endocytosis in excitable cells
$2,281,322Justin Taraska · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Multimodal Developmental Neurogenetics of Females with ASD
$2,281,273Kevin A. Pelphrey · University Of Virginia · R01 · FY2021 · MH
Ancillary Study
$2,281,109Joshua A Boyce · Brigham And Women'S Hospital · U01 · FY2012 · HL
Full human gene-replacement mouse models of ADRDs
$2,280,898Michael D Koob · University Of Minnesota · R33 · FY2021 · NS
Molecular Therapeutics for Anaplastic Gliomas
$2,280,865University Of Alabama At Birmingham · P50 · FY2003 · CA
Mechanisms that Govern Cardiomyocyte Proliferation and Remuscularization following Ventricular Injury
$2,280,760Jianyi Zhang · University Of Alabama At Birmingham · P01 · FY2024 · HL
SPORE: Targeted Therapies for Glioma
$2,280,112Tracy T Batchelor · Massachusetts General Hospital · P50 · FY2017 · CA
Successful Clinical Response In Pneumonia Therapy (SCRIPT) Systems Biology Center
$2,280,000Richard G Wunderink · Northwestern University At Chicago · U19 · FY2022 · AI
Successful Clinical Response In Pneumonia Therapy (SCRIPT) Systems Biology Center
$2,280,000Richard G Wunderink · Northwestern University At Chicago · U19 · FY2021 · AI
MICRORNA AND NEURAL FACTOR-MEDIATED DIRECT REPROGRAMMING OF CELL FATES
$2,280,000Andrew Yoo · Washington University · DP2 · FY2012 · NS
Section on Skeletal Disorders and Mineral Homeostasis
$2,279,342Michael Collins · National Institute Of Dental & Craniofacial Research · ZIA · FY2017 · DE
Center for the Development of Phenotype-Based Treatments of Autism Spectrum Disorder
$2,279,021David G Amaral · University Of California At Davis · P50 · FY2019 · HD
Genomic and epigenomic mechanisms of pediatric ocular disorders
$2,278,931Robert Hufnagel · National Eye Institute · ZIA · FY2022 · EY